Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$739M |
| 2 |
Progressive
PGR
|
+$435M |
| 3 |
Danaher
DHR
|
+$362M |
| 4 |
Revvity
RVTY
|
+$314M |
| 5 |
Netflix
NFLX
|
+$308M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$648M |
| 2 |
Microsoft
MSFT
|
+$569M |
| 3 |
AbbVie
ABBV
|
+$406M |
| 4 |
NVIDIA
NVDA
|
+$351M |
| 5 |
Eli Lilly
LLY
|
+$350M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.65% |
| 2 | Healthcare | 19.35% |
| 3 | Industrials | 10.08% |
| 4 | Financials | 10% |
| 5 | Consumer Discretionary | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Schwab US Large- Cap ETF
SCHX
$70.9B
| $188M | 0.12% |
10,767,582
-242,373
| -2% | -$4M |
|
|
FOLD
177
DELISTED
Amicus Therapeutics
FOLD
| $187M | 0.12% |
14,923,588
+1,313,153
| +10% | +$15.6M |
|
178
Sensient Technologies
SXT
$5.4B
| $184M | 0.11% |
2,592,266
-12,000
| -0.5% | -$891K |
|
179
Constellium
CSTM
$3.96B
| $183M | 0.11% |
10,649,062
-682
| -0% | -$10.5K |
|
180
OSI Systems
OSIS
$3.57B
| $183M | 0.11% |
1,553,717
-195,613
| -11% | -$22.4M |
|
181
Dollar Tree
DLTR
$23.1B
| $182M | 0.11% |
1,268,942
+258,809
| +26% | +$38.1M |
|
182
Core & Main
CNM
$8.17B
| $181M | 0.11% |
5,764,284
-2,080,354
| -27% | -$55.7M |
|
183
Autodesk
ADSK
$44.3B
| $180M | 0.11% |
880,446
+2,628
| +0.3% | +$526K |
|
184
Neurocrine Biosciences
NBIX
$17.7B
| $180M | 0.11% |
1,908,844
-85,677
| -4% | -$8.37M |
|
185
EOG Resources
EOG
$78B
| $180M | 0.11% |
1,572,083
-813,554
| -34% | -$92.9M |
|
186
Apollo Global Management
APO
$70.7B
| $179M | 0.11% |
2,333,189
-127,850
| -5% | -$8.55M |
|
187
DexCom
DXCM
$27.6B
| $178M | 0.11% |
1,381,939
+608,423
| +79% | +$73.6M |
|
188
Alight
ALIT
$497M
| $172M | 0.11% |
929,378
+56,448
| +6% | +$10M |
|
189
Walker & Dunlop
WD
$1.65B
| $167M | 0.1% |
2,111,361
+76,787
| +4% | +$5.55M |
|
190
Xylem
XYL
$28.5B
| $164M | 0.1% |
1,459,202
+56,958
| +4% | +$6.02M |
|
191
AstraZeneca
AZN
$263B
| $164M | 0.1% |
1,142,916
-194,792
| -15% | -$28.7M |
|
192
STAG Industrial
STAG
$7.86B
| $164M | 0.1% |
4,559,218
-739,712
| -14% | -$25.6M |
|
|
APLS
193
DELISTED
Apellis Pharmaceuticals
APLS
| $162M | 0.1% |
1,776,905
-2,904,577
| -62% | -$251M |
|
194
PNC Financial Services
PNC
$100B
| $162M | 0.1% |
1,283,196
+1,222,230
| +2,005% | +$149M |
|
195
Euronet Worldwide
EEFT
$3.02B
| $161M | 0.1% |
1,375,792
-851
| -0.1% | -$95.1K |
|
196
Cencora
COR
$60.3B
| $161M | 0.1% |
837,975
-53,568
| -6% | -$9.27M |
|
197
Cimpress
CMPR
$2.37B
| $159M | 0.1% |
2,678,553
+22,618
| +0.9% | +$1.11M |
|
198
Ambev
ABEV
$47.3B
| $158M | 0.1% |
49,858,560
+29,000
| +0.1% | +$85.3K |
|
199
Waters Corp
WAT
$36.8B
| $155M | 0.1% |
580,481
+197,600
| +52% | +$55M |
|
200
Aptiv
APTV
$12B
| $153M | 0.1% |
1,499,629
+204,467
| +16% | +$20.2M |
|
Similar funds
Janus Henderson Group's Q2 2023 Portfolio in Review
As of Q2 2023, Janus Henderson Group held 2,758 positions worth $161B, up 6% from $152B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q2 2023 filing shows 73 new, 782 increased, 1,689 reduced and 166 closed positions. Its largest new stake was ATS Corp: 1,554,233 shares worth $71.6M. The largest sale was Advanced Micro Devices, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q2 2023 buy was ATS Corp: 1,554,233 shares worth $71.6M.
- Janus Henderson Group added most to Meta Platforms (Facebook) in Q2 2023, an estimated $739M increase.
- Janus Henderson Group's biggest Q2 2023 reduction was Advanced Micro Devices, cutting an estimated $648M.
- Janus Henderson Group fully exited Warner Music in Q2 2023, selling an estimated $50.6M.
- Janus Henderson Group's ten largest holdings make up 24% of its $161B portfolio in Q2 2023.
- Janus Henderson Group opened 73 new positions and closed 166 in Q2 2023.
- Janus Henderson Group's portfolio value rose 6% quarter-over-quarter to $161B.
Based on Janus Henderson Group's 13F filing for Q2 2023, filed 14 Aug 2023.